Video Experimental Relacionado
Updated: Jul 15, 2026
07:25
Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights
Published on: October 13, 2023
Síndrome de Sjögren primario y deficiencia de ICA69
Shawn Winer1, Igor Astsaturov, Roy Cheung
1Hospital for Sick Children, Research Institute, ON, Toronto, Canada.
Lancet (London, England)
|October 18, 2002
Resumen
ICA69 se identifica como un autoantígeno clave en el síndrome de Sjögren, impulsando la progresión de la enfermedad. La inmunoterapia dirigida a ICA69 es prometedora para tratar esta afección autoinmune, incluso en etapas posteriores.
Área de la Ciencia:
- Inmunología Inmunología.
- La autoinmunidad es autoinmunidad.
- Endocrinología Endocrinología.
Sus antecedentes:
- El síndrome de Sjögren es un trastorno autoinmune prevalente que afecta a las glándulas salivales y lagrimales.
- La causa exacta y la patogénesis del síndrome de Sjögren siguen siendo poco conocidas.
- ICA69, un autoantígeno que se encuentra en varias glándulas, está implicado en las respuestas autoinmunes.
Objetivo del estudio:
- Investigar el papel de ICA69 en el desarrollo de la autoinmunidad del síndrome de Sjögren.
- Evaluar el potencial de ICA69 como marcador de diagnóstico y objetivo terapéutico.
Principales métodos:
- Generó ratones congénitos NOD con deficiencia de ICA69 para modelar el síndrome de Sjögren.
- Se analizó la autoinmunidad de ICA69 en pacientes con síndrome de Sjögren primario y lupus eritematoso sistémico.
- Evaluó la eficacia de un prototipo de vacuna péptida dirigida a ICA69 en ratones NOD.
Principales resultados:
- La deficiencia de ICA69 protegió a los ratones NOD de la enfermedad de la glándula lacrimal y la enfermedad de la glándula salival reducida.
- Se observó una acumulación de células T específicas de ICA69 en los ganglios linfáticos que drenan la saliva de ratones NOD.
- La autorreactividad contra ICA69 fue prevalente en los pacientes con síndrome de Sjögren primario, pero no en los controles ni en los pacientes con LES.
- La vacunación terapéutica con péptido dirigida a ICA69 redujo el síndrome de Sjögren establecido en ratones NOD.
Conclusiones:
- ICA69 es un nuevo autoantígeno que contribuye a la progresión del síndrome de Sjögren y puede servir como un marcador de diagnóstico.
- La inmunoterapia dirigida a ICA69 demuestra potencial para el tratamiento del síndrome de Sjögren, mostrando eficacia incluso en etapas avanzadas de la enfermedad en un modelo animal relevante.
Videos de Conceptos Relacionados
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...